We retrospectively reviewed time to response and incidence of delayed responses in 13 patients with lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia (LPL/WM) treated with fludarabine with or without cyclophosphamide. During follow-up post-treatment, seven delayed responses (54%) were observed, improving the initial overall response rate of 61% to a final response rate of 77%.
Delayed response to fludarabine in lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia / DEL GIUDICE, Ilaria; E., Matutes; N., Osuji; N., Parry Jones; J., Swansbury; D., Catovsky. - In: HAEMATOLOGICA. - ISSN 0390-6078. - STAMPA. - 90:(2005), pp. 268-270.
Delayed response to fludarabine in lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia.
DEL GIUDICE, ILARIA;
2005
Abstract
We retrospectively reviewed time to response and incidence of delayed responses in 13 patients with lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia (LPL/WM) treated with fludarabine with or without cyclophosphamide. During follow-up post-treatment, seven delayed responses (54%) were observed, improving the initial overall response rate of 61% to a final response rate of 77%.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
